Medicare Enrolled
Dr. Nashib Hashmi, M.D.
Nephrology · Kankakee, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hashmi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hashmi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hashmi
Dr. Nashib Hashmi is a nephrology specialist in Kankakee, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hashmi performed 5,091 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Hashmi received a total of $12,700 from 44 pharmaceutical and/or device companies across 528 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hashmi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 2% volume in IL
$12,700 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,091
Medicare services
Top 2% in IL for nephrology
Not available
Unique patients (not deduplicated)
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
1,231 | $49 | $100 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
663 | $37 | $75 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
630 | $63 | $141 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
533 | $97 | $251 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
450 | $31 | $79 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
311 | $67 | $178 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
271 | $37 | $102 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
265 | $38 | $96 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
184 | $278 | $708 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
111 | $138 | $389 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
95 | $104 | $269 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
91 | $94 | $202 |
| Home dialysis services per month Monthly dialysis treatment provided in the patient's home for individuals aged 20 or older. |
75 | $229 | $587 |
| Hemodialysis, single evaluation A dialysis procedure to filter waste from the blood, performed with a physician's evaluation. |
52 | $57 | $144 |
| Dialysis procedure with evaluation A dialysis treatment that includes one evaluation. |
51 | $67 | $170 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
40 | $122 | $332 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
38 | $231 | $587 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$12,700
Total received (2018-2024)
Avg $1,814/year across 7 years
Top 9% in IL for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
528
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,761
2023
$2,151
2022
$2,340
2021
$1,512
2020
$1,054
2019
$1,876
2018
$1,007
Payments by company (2024)
Mallinckrodt Hospital Products Inc.
$360
OPKO Pharmaceuticals, LLC
$332
Novo Nordisk Inc
$313
AstraZeneca Pharmaceuticals LP
$311
ANI Pharmaceuticals, Inc.
$214
Amgen Inc.
$214
CALLIDITAS THERAPEUTICS US INC.
$152
Travere Therapeutics, Inc.
$133
Novartis Pharmaceuticals Corporation
$125
Ardelyx, Inc.
$122
Otsuka America Pharmaceutical, Inc.
$97
Boehringer Ingelheim Pharmaceuticals, Inc.
$78
GlaxoSmithKline, LLC.
$69
Vifor Pharma, Inc.
$55
Lilly USA, LLC
$48
SHIELD THERAPEUTICS INC
$30
Bausch Health US, LLC
$23
Xeris Pharmaceuticals, Inc.
$22
Takeda Pharmaceuticals U.S.A., Inc.
$22
Renalytix AI, Inc.
$16
Bayer Healthcare Pharmaceuticals Inc.
$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$13
Top 3 companies account for 36.4% of 2024 payments
All-time payments by company (2018-2024) ›
OPKO Pharmaceuticals, LLC
$1,514
Mallinckrodt Hospital Products Inc.
$1,479
AstraZeneca Pharmaceuticals LP
$1,203
Amgen Inc.
$1,087
Vifor Pharma, Inc.
$929
Travere Therapeutics, Inc.
$608
Otsuka America Pharmaceutical, Inc.
$531
Novo Nordisk Inc
$488
Relypsa, Inc.
$450
GlaxoSmithKline, LLC.
$424
AKEBIA THERAPEUTICS INC
$406
Bayer HealthCare Pharmaceuticals Inc.
$322
ANI Pharmaceuticals, Inc.
$271
Mallinckrodt Enterprises LLC
$262
Fresenius USA Marketing, Inc.
$239
Takeda Pharmaceuticals U.S.A., Inc.
$237
Boehringer Ingelheim Pharmaceuticals, Inc.
$235
Keryx Biopharmaceuticals, Inc.
$196
Aurinia Pharma U.S., Inc.
$180
Horizon Therapeutics plc
$171
CALLIDITAS THERAPEUTICS US INC.
$168
Retrophin, Inc.
$129
Novartis Pharmaceuticals Corporation
$125
Bayer Healthcare Pharmaceuticals Inc.
$125
Ardelyx, Inc.
$122
Lilly USA, LLC
$94
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$71
Exeltis, USA Inc.
$70
Mallinckrodt LLC
$70
AMAG Pharmaceuticals, Inc.
$64
Daiichi Sankyo Inc.
$54
Horizon Pharma plc
$47
Octapharma USA, Inc.
$43
Shire North American Group Inc
$38
Renalytix AI, Inc.
$37
Alnylam Pharmaceuticals Inc.
$34
Baxter Healthcare
$32
SHIELD THERAPEUTICS INC
$30
TissueTech, Inc.
$24
Bausch Health US, LLC
$23
Xeris Pharmaceuticals, Inc.
$22
Alexion Pharmaceuticals, Inc.
$18
Otsuka Pharmaceutical Development & Commercialization, Inc.
$17
Hikma Pharmaceuticals USA
$11
Top 3 companies account for 33.0% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ACCRUFER · ACTHAR · APLENZIN · AURYXIA · Aranesp · Auryxia · BENLYSTA · EVENITY · FARXIGA · FERAHEME · GATTEX · IBSRELA · INJECTAFER · JARDIANCE · JESDUVROQ · JYNARQUE · KEVEYIS · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · KRYSTEXXA · Kerendia · LOKELMA · LUPKYNIS · MOUNJARO · Mitigare · OCTAPLAS · OXLUMO · Ozempic · PURIFIED CORTROPHIN GEL · Parsabiv · Prokera · Prolia · RAYALDEE · Rayaldee · Rayaldee (old) · Renal - PD · Rybelsus · SAMSCA · TARPEYO · TAVNEOS · TRULICITY · Thiola · Tresiba · Uloric · Ultomiris · Velphoro · Veltassa · Victoza · Wegovy · XIFAXAN
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Nephrologists in nearby ZIP areas
3
County median income
$68,325
Nearest hospital to ZIP centroid (approximate)
PRESENCE ST MARYS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hashmi is a clinical cardiology specialist, with above-average Medicare volume (top 2% in IL), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hashmi experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Hashmi performed 1,231 chronic care management, first 20 min/month services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Hashmi receive payments from pharmaceutical companies?
Yes. Dr. Hashmi received a total of $12,700 from 44 companies across 528 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hashmi's costs compare to other nephrologists in Kankakee?
Dr. Hashmi's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hashmi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in Kankakee
Browse nephrologists in Kankakee ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in IL
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in IL
Which IL nephrologists receive the most from drug and device companies.
By company
OPKO Pharmaceuticals, LLC Payments to Doctors
See all physicians who received payments from OPKO Pharmaceuticals, LLC.
By company
Mallinckrodt Hospital Products Inc. Payments to Doctors
See all physicians who received payments from Mallinckrodt Hospital Products Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology